Your browser doesn't support javascript.
loading
Spironolactone in Acute Heart Failure Patients With Renal Dysfunction and Risk Factors for Diuretic Resistance: From the ATHENA-HF Trial.
Greene, Stephen J; Felker, G Michael; Giczewska, Anna; Kalogeropoulos, Andreas P; Ambrosy, Andrew P; Chakraborty, Hrishikesh; DeVore, Adam D; Fudim, Marat; McNulty, Steven E; Mentz, Robert J; Vaduganathan, Muthiah; Hernandez, Adrian F; Butler, Javed.
Afiliação
  • Greene SJ; Duke Clinical Research Institute, Durham, North Carolina, USA; Division of Cardiology, Duke University School of Medicine, Durham, North Carolina, USA. Electronic address: stephen.greene@duke.edu.
  • Felker GM; Duke Clinical Research Institute, Durham, North Carolina, USA; Division of Cardiology, Duke University School of Medicine, Durham, North Carolina, USA.
  • Giczewska A; Duke Clinical Research Institute, Durham, North Carolina, USA; Department of Biomedical Engineering, Faculty of Electronics, Telecommunications and Informatics, Gdansk University of Technology, Gdansk, Poland.
  • Kalogeropoulos AP; Division of Cardiology, Stony Brook University, Stony Brook, New York, USA.
  • Ambrosy AP; Department of Cardiology, Kaiser Permanente San Francisco Medical Center, San Francisco, California, USA; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.
  • Chakraborty H; Duke Clinical Research Institute, Durham, North Carolina, USA.
  • DeVore AD; Duke Clinical Research Institute, Durham, North Carolina, USA; Division of Cardiology, Duke University School of Medicine, Durham, North Carolina, USA.
  • Fudim M; Duke Clinical Research Institute, Durham, North Carolina, USA; Division of Cardiology, Duke University School of Medicine, Durham, North Carolina, USA.
  • McNulty SE; Duke Clinical Research Institute, Durham, North Carolina, USA.
  • Mentz RJ; Duke Clinical Research Institute, Durham, North Carolina, USA; Division of Cardiology, Duke University School of Medicine, Durham, North Carolina, USA.
  • Vaduganathan M; Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, Boston, Massachusetts, USA.
  • Hernandez AF; Duke Clinical Research Institute, Durham, North Carolina, USA; Division of Cardiology, Duke University School of Medicine, Durham, North Carolina, USA.
  • Butler J; Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA.
Can J Cardiol ; 35(9): 1097-1105, 2019 09.
Article em En | MEDLINE | ID: mdl-31230825

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espironolactona / Resistência a Medicamentos / Insuficiência Renal / Taxa de Filtração Glomerular / Insuficiência Cardíaca Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Can J Cardiol Assunto da revista: CARDIOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espironolactona / Resistência a Medicamentos / Insuficiência Renal / Taxa de Filtração Glomerular / Insuficiência Cardíaca Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Can J Cardiol Assunto da revista: CARDIOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de publicação: Reino Unido